Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
Results from a real-world clinical study conducted in China, to be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress, reveal that modern lifestyles and environmental triggers significantly impact individuals with sensitive skin[1]
Data show that people with sensitive skin living in modern environments have higher levels of inflammation compared to those living traditional, less stressful lifestyles[1]
This first-of-its-kind study was conducted by Galderma’s Global Sensitive Skincare Faculty (GSSF) as part of the company’s commitment to transforming the understanding and care of sensitive skin[1]
Aaron Farberg, MD, Dermatologist and Mohs Surgeon, Baylor Scott & White Health, United States, Member of the Galderma Global Sensitive Skincare Faculty
“This clinical study delivers compelling biological evidence that sensitive skin responds differently and more intensely to the pressures of modern living. These findings validate what many clinicians observe but rarely see quantified: that pollution, stress, and poor sleep can visibly and measurably aggravate sensitive skin. Through this research, Galderma’s Global Sensitive Skincare Faculty is working to elevate sensitive skin from a subjective complaint to a scientifically understood condition, helping pave the way for better diagnosis, education, and care.”
AARON FARBERG, MD
DERMATOLOGIST AND MOHS SURGEON
BAYLOR SCOTT & WHITE HEALTH, UNITED STATES
The clinical study enrolled 150 women from China aged 35-50, divided into three equal groups: individuals with sensitive skin living in modern, urban environments; individuals with sensitive skin living in traditional, less urbanized settings; and individuals with non-sensitive skin living in modern environments.[1] Participants in modern environments experienced higher pollution, stress, and poorer sleep compared to those in traditional settings.[1] The study compared skin health across these groups to assess the impact of both lifestyle and skin sensitivity.[1]
Modern living leaves a mark
Results from a tape-stripping analysis of the outermost layer of the skin (the stratum corneum) reveal that sensitive skin faces a triple threat: inflammation, oxidative stress, and environmental damage.[1]
The study revealed significant biological differences in people with sensitive skin; people living in modern environments exhibited three times more inflammation than those in traditional environments, as evidenced by elevated levels of the inflammatory marker, prostaglandin E2.[1] Inflammation plays a key role in sensitive skin by activating immune responses that lead to redness, discomfort, and barrier disruption, making the skin more reactive to environmental stressors.[1]
The findings also point to oxidative stress - a biological response to environmental stressors like UV exposure and pollution which triggers skin aging - playing a central role in sensitive skin.[1] Individuals with sensitive skin in modern environments showed a 16% increase in oxidative stress markers compared to non-sensitive skin, indicating an exaggerated response that may accelerate skin damage and compromise long-term skin health.[1] Notably, consistently high oxidative stress levels were observed in sensitive skin regardless of lifestyle, suggesting that oxidative stress may be a core driver of sensitive skin.[1]
In addition, a higher level of dark spots commonly associated with photoaging was observed in sensitive skin, providing visible evidence of the long-term impact of environmental stressors on skin integrity and appearance.[1]
Taken together, these findings underscore the profound influence of environmental factors on sensitive skin, particularly in modern urban settings.[1] The combination of heightened inflammation, persistent oxidative stress, and visible signs of damage points to a biologically distinct skin profile that is more vulnerable to internal and external triggers.[1]
Full results from the study will be presented during the GSSF industry hub titled, “Sensitive skin syndrome: A rising phenomenon linked to modern lifestyles and environmental changes” on Friday, September 19 from 11:15 AM - 12:00 PM CET, Hub 2.
Galderma’s mission to improve the lives of those with sensitive skin is reflected in its robust presence at EADV, where the company will also present its latest sensitive skin research across five abstracts, and host Meet the Expert sessions dedicated to its flagship gentle skincare brand, Cetaphil®, at the company’s booth (#EO1). By fostering education and supporting innovative research initiatives, Galderma is helping to transform the field of dermatology and deliver meaningful solutions for people living with sensitive skin.
More information about Galderma’s activities at EADV can be found here.
About Galderma’s Global Sensitive Skincare Faculty (GSSF)
The GSSF is a pioneering international initiative dedicated to advancing the understanding, diagnosis, and care of sensitive skin. Bringing together leading dermatology experts from around the world, GSSF conducts inclusive, science-led research to explore factors that contribute to the rise and severity of sensitive skin conditions, such as modern living and climate change. Through landmark studies like the largest-ever epidemiological survey on sensitive skin, GSSF is uncovering the biological realities of sensitive skin across diverse populations. Its mission is to elevate sensitive skin from a subjective complaint to a scientifically recognized condition, driving innovation, education, and improved dermatological outcomes globally.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
References
[1] Friedman A. Sensitive skin syndrome: A rising phenomenon linked to modern lifestyles and environmental changes. Presented as an industry hub at the European Academy of Dermatology and Venereology Congress; September 17-20, 2025; Paris, France.
[2] Richters R, et al. What Is Sensitive Skin? A Systematic Literature Review of Objective Measurements. Skin Pharmacol Physiol. 2015;28,75-83. doi:10.1159/000363149.
[3] Vidal S, et al. Defining the Prevalence, Clinical Characteristics, and Demographic Influences on Patients with Sensitive Skin Syndrome: Insights from the Largest Global Survey of Sensitive Skin. Poster presented at the EADV Congress; September 17-20, 2025; Paris, France
[4] Prescott SL, et al. The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. WAO Journal. 2017;22,10(1):29. doi:10.1186/s40413-017-0160-5.
[5] Chen X, et al. A review of factors influencing sensitive skin: an emphasis on built environment characteristics. Front. Public Health. 2023;11,1269314. doi:10.3389/fpubh.2023.1269314.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250916245806/en/
Attachments:
Sensitive skin and modern lifestyles Media Factsheet.pdf
Website: http://www.galderma.com
Contact
Galderma SA
Christian Marcoux, M.Sc.
Chief Communications Officer
+41 76 315 26 50
christian.marcoux@galderma.com
Richard Harbinson
Corporate Communications Director
+41 76 210 60 62
richard.harbinson@galderma.com
Céline Buguet
Franchises and R&D Communications Director
+41 76 249 90 87
celine.buguet@galderma.com
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
+41 21 642 78 12
emil.ivanov@galderma.com
Jessica Cohen
Investor Relations and Strategy Director
+41 21 642 76 43
jessica.cohen@galderma.com
This news is a press release provided by Galderma.
-
9월 11일 15:50
-
9월 10일 16:30